However, the addition of atRA to IL-2 and TGF-β completes the maturation of these partially differentiated cells and enables them to protect immunodeficient mice from a xeno-GVHD at least as well as expanded human nTreg cells. The gene discussed is IL2; the disease is graft versus host disease.